DK226288A - Fremgangsmaade til fremstilling af lak-celler in vitro - Google Patents

Fremgangsmaade til fremstilling af lak-celler in vitro

Info

Publication number
DK226288A
DK226288A DK226288A DK226288A DK226288A DK 226288 A DK226288 A DK 226288A DK 226288 A DK226288 A DK 226288A DK 226288 A DK226288 A DK 226288A DK 226288 A DK226288 A DK 226288A
Authority
DK
Denmark
Prior art keywords
vitro
manufacturing
lak cells
centrifugation
standard
Prior art date
Application number
DK226288A
Other languages
English (en)
Other versions
DK226288D0 (da
Inventor
Jr George Franks Dunn
Joseph David Irr
Lise Nadine Halpern
Original Assignee
Du Pont
Haemonetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont, Haemonetics Corp filed Critical Du Pont
Publication of DK226288D0 publication Critical patent/DK226288D0/da
Publication of DK226288A publication Critical patent/DK226288A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK226288A 1987-04-27 1988-04-26 Fremgangsmaade til fremstilling af lak-celler in vitro DK226288A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/042,998 US4808151A (en) 1987-04-27 1987-04-27 Simplified method for the preparation of human lymphokine activated killer cells

Publications (2)

Publication Number Publication Date
DK226288D0 DK226288D0 (da) 1988-04-26
DK226288A true DK226288A (da) 1988-10-28

Family

ID=21924902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK226288A DK226288A (da) 1987-04-27 1988-04-26 Fremgangsmaade til fremstilling af lak-celler in vitro

Country Status (17)

Country Link
US (1) US4808151A (da)
EP (1) EP0289896B1 (da)
JP (1) JPH0657147B2 (da)
KR (1) KR900004422B1 (da)
AT (1) ATE78053T1 (da)
AU (1) AU612086B2 (da)
CA (1) CA1304306C (da)
DE (1) DE3872588T2 (da)
DK (1) DK226288A (da)
ES (1) ES2051790T3 (da)
FI (1) FI881952L (da)
HU (1) HU205380B (da)
IL (1) IL86177A0 (da)
NO (1) NO881819L (da)
NZ (1) NZ224379A (da)
PT (1) PT87335B (da)
ZA (1) ZA882948B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7873187A (en) * 1986-08-08 1988-02-24 University Of Minnesota Method of culturing leukocytes
AU4485089A (en) * 1988-10-21 1990-05-14 Brigham And Women's Hospital Activation and growth of human tumor-infiltrating lymphocytes using antibodies to cd3 or tcr
DE68927679T2 (de) * 1988-10-27 1997-06-26 Univ Minnesota Immunhilfsmittel aus Liposome enthaltend Lymphokin IL -2
US5484396A (en) * 1988-11-17 1996-01-16 Naficy; Sadeque S. Method and device for treatment of HIV infections and AIDS
WO1990010059A1 (en) * 1989-02-21 1990-09-07 Terumo Corporation A process for the generation of proliferating cd4 lymphocytes
US5843728A (en) * 1991-03-07 1998-12-01 The General Hospital Corporation Redirection of cellular immunity by receptor chimeras
US5912170A (en) 1991-03-07 1999-06-15 The General Hospital Corporation Redirection of cellular immunity by protein-tyrosine kinase chimeras
US6004811A (en) 1991-03-07 1999-12-21 The Massachussetts General Hospital Redirection of cellular immunity by protein tyrosine kinase chimeras
US6753162B1 (en) 1991-03-07 2004-06-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US7049136B2 (en) 1991-03-07 2006-05-23 The General Hospital Corporation Redirection of cellular immunity by receptor chimeras
US5851828A (en) * 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US5725855A (en) * 1991-04-05 1998-03-10 The United States Of America As Represented By The Department Of Health And Human Services Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
JPH06506465A (ja) * 1991-04-05 1994-07-21 リージエンツ・オブ・ザ・ユニバーシテイ・オブ・ミネソタ 細胞サブセットの欠落／陽性選択による免疫細胞の免疫療法活性の増強方法
IE922233A1 (en) * 1991-07-10 1993-01-13 Augusto C Ochoa Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
AU3423493A (en) * 1991-12-31 1993-07-28 Zymogenetics Inc. Methods and compositions for reducing blood loss
US6022306A (en) * 1995-04-18 2000-02-08 Cobe Laboratories, Inc. Method and apparatus for collecting hyperconcentrated platelets
US6053856A (en) * 1995-04-18 2000-04-25 Cobe Laboratories Tubing set apparatus and method for separation of fluid components
US5939319A (en) * 1995-04-18 1999-08-17 Cobe Laboratories, Inc. Particle separation method and apparatus
US5913768A (en) * 1995-04-18 1999-06-22 Cobe Laboratories, Inc. Particle filter apparatus
US5674173A (en) * 1995-04-18 1997-10-07 Cobe Laboratories, Inc. Apparatus for separating particles
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
US6051146A (en) * 1998-01-20 2000-04-18 Cobe Laboratories, Inc. Methods for separation of particles
US6153113A (en) * 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
US6334842B1 (en) 1999-03-16 2002-01-01 Gambro, Inc. Centrifugal separation apparatus and method for separating fluid components
US6354986B1 (en) 2000-02-16 2002-03-12 Gambro, Inc. Reverse-flow chamber purging during centrifugal separation
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
WO2003050536A2 (en) * 2001-12-05 2003-06-19 Gambro, Inc. Methods and apparatus for separation of blood components
US20030173274A1 (en) * 2002-02-01 2003-09-18 Frank Corbin Blood component separation device, system, and method including filtration
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
US7279107B2 (en) * 2002-04-16 2007-10-09 Gambro, Inc. Blood component processing system, apparatus, and method
CN1291231C (zh) * 2003-12-08 2006-12-20 胡军 活化淋巴细胞特异性的检测方法
WO2008021623A1 (en) * 2006-08-10 2008-02-21 Gambro Bct, Inc. Method and apparatus for recirculating elutriation fluids
DE102011106914B4 (de) 2011-07-08 2015-08-27 Zellwerk Gmbh Mäander- Bioreaktor und Verfahren zu dynamischen Expansion, Differenzierung und Ernte von hämatopoetischen Zellen
US9248446B2 (en) 2013-02-18 2016-02-02 Terumo Bct, Inc. System for blood separation with a separation chamber having an internal gravity valve
KR102181610B1 (ko) * 2016-06-03 2020-11-23 주식회사 젬백스앤카엘 항암 치료용 사이토카인 유도 살해세포의 생산 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145713A (en) * 1963-09-12 1964-08-25 Protein Foundation Inc Method and apparatus for processing blood
US4197847A (en) * 1977-03-31 1980-04-15 Isaac Djerassi Method and apparatus for collecting transfusable granulocytes
US4185629A (en) * 1977-10-18 1980-01-29 Baxter Travenol Laboratories, Inc. Method and apparatus for processing blood
US4151844A (en) * 1977-11-11 1979-05-01 Baxter Travenol Laboratories, Inc. Method and apparatus for separating whole blood into its components and for automatically collecting one component
US4285464A (en) * 1979-01-22 1981-08-25 Haemonetics Corporation Apparatus for separation of blood into components thereof
US4401756A (en) * 1981-04-14 1983-08-30 Immunex Corporation Process for preparing human interleukin 2
US4464166A (en) * 1981-06-12 1984-08-07 Frederic A. Bourke, Jr. Method for externally treating the blood
US4416654A (en) * 1981-09-03 1983-11-22 Haemonetics Corporation Pheresis apparatus
US4464167A (en) * 1981-09-03 1984-08-07 Haemonetics Corporation Pheresis apparatus
JPS5998015A (ja) * 1982-11-27 1984-06-06 Microbial Chem Res Found 免疫賦活剤
US4613322A (en) * 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
US4683889A (en) * 1983-03-29 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4675383A (en) * 1983-11-15 1987-06-23 The Salk Institute For Biological Studies Purification of T-cell growth factor
US4578056A (en) * 1984-10-29 1986-03-25 Extracorporeal Medical Specialties, Inc. Patient photopheresis treatment apparatus and method
US4690915A (en) * 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans

Also Published As

Publication number Publication date
DK226288D0 (da) 1988-04-26
EP0289896B1 (en) 1992-07-08
KR900004422B1 (ko) 1990-06-25
FI881952A7 (fi) 1988-10-28
FI881952L (fi) 1988-10-28
JPH0657147B2 (ja) 1994-08-03
CA1304306C (en) 1992-06-30
DE3872588D1 (de) 1992-08-13
IL86177A0 (en) 1988-11-15
NZ224379A (en) 1990-12-21
NO881819L (no) 1988-10-28
ATE78053T1 (de) 1992-07-15
HU205380B (en) 1992-04-28
DE3872588T2 (de) 1992-12-03
AU1520088A (en) 1988-10-27
PT87335B (pt) 1992-08-31
US4808151A (en) 1989-02-28
FI881952A0 (fi) 1988-04-26
AU612086B2 (en) 1991-06-27
ES2051790T3 (es) 1994-07-01
NO881819D0 (no) 1988-04-26
EP0289896A1 (en) 1988-11-09
ZA882948B (en) 1989-12-27
JPS63295510A (ja) 1988-12-01
PT87335A (pt) 1988-05-01
KR880012751A (ko) 1988-11-29

Similar Documents

Publication Publication Date Title
DK226288A (da) Fremgangsmaade til fremstilling af lak-celler in vitro
AU606894B2 (en) Viable cell labelling
AU641488B2 (en) Human hematopoietic stem cell
GB8513190D0 (en) Combustion of fuel & oxygen
ES2120946T3 (es) Sistemas y medios de cultivo celular.
EP0453453A4 (en) Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
DE69332024D1 (de) Die trennung lebender säugetierzellen durch hoch geschwindigkeits-durchflusscytometrie
NZ223221A (en) Separation of leucocytes and erythrocytes by sedimentation
DE3676628D1 (de) Fermentationsanlage.
AU2925789A (en) Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection
EP0257962A3 (en) Method for treatment of peripheral blood to improve lymphokine activated killer immunotherapy
EP0112154A3 (en) Method for culturing living cells
MY103370A (en) A simplified method for the preparation of human lymphokine activated killer cells
EP0201800A3 (en) A cholesterol-rich fraction, process therefor and use thereof in cell culture
FI871830A0 (fi) Immobilisering av celler som inte fastnar vid en baerare.
SU1082422A1 (ru) Способ определени активности интерферона в сыворотке и плазме крови
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
FR2585722B1 (fr) Co-cultures d'hepatocytes et de cellules epitheliales de foie traitees
UA12063A1 (uk) Спосіб культивуваhhя острівцевих клітиh підшлуhкової залози
QIU et al. Changes of CD28, CD56 and CD57 expression on CD8+ T cells in the peripheral blood of healthy elderly individuals
UA2122A1 (uk) Диск турбомашини
KR870008023A (ko) 락트 알부민 하이드로리 세이트의 첨가에 의한 인터페론의 생산 증강법

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment